PremiumThe FlyCSL initiated with a Buy at Goldman Sachs CSL receives positive CHMP opinion for garadacimab in HAE Travere Therapeutics, CSL Vifor announce Swissmedic approval of FILSPARI PremiumThe FlyArcturus Therapeutics and CSL’ ARCT-154 shows superior immunogenicity Arcturus Therapeutics, CSL publish data on booster dose of ARCT-154 CSL upgraded to Conviction Buy from Buy at Goldman Sachs PremiumThe FlyJefferies healthcare analyst holds an analyst/industry conference call CSL Seqirus begins shipping portfolio of flu vaccines for 2023/24 U.S. season CSL says first patient receives FDA-approved HEMGENIX in U.S. 
